Listed by the USPTO as CASH, KAILEY ELIZABETH
Tech Center 1600 • Art Units: 1637 1672 1682 1683
This examiner grants 29% of resolved cases
CASH, KAILEY ELIZABETH is a USPTO patent examiner in tech center 1600 and art unit 1637. The record contains 21 resolved cases, with an allowance rate of 28.6% and a median of 1351 days to allowance. The interview lift is 64.3%, indicating a strong association between interviews and allowance outcomes within a limited record.
Company matters include THE GENERAL HOSPITAL Corporation, Rprd Diagnostics LLC, and Abbott Laboratories. The associated firms are pH IP Law, WILSON SONSINI GOODRICH & ROSATI, and ALSTON & BIRD LLP. Practitioners should prepare carefully for interviews while treating the small resolved-case record as directional and planning for an extended prosecution timeline.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18557631 | HIGH THROUGHPUT NUCLEIC ACID TESTING OF BIOLOGICAL SAMPLES | Non-Final OA | ABBOTT LABORATORIES |
| 17687376 | SYSTEMS AND METHODS FOR BARCODING CELLS AND CELL BEADS | Non-Final OA | 10x Genomics, Inc. |
| 18203189 | Quantum Dot-Peptide PNA-DNA Complexes as a Platform Reporter System for Multiplexed Detection in Cell-Free Transcription Translation-Based Biosensors | Non-Final OA | The Government of the United States of America, as represented by the Secretary of the Navy |
| 18468384 | PANELS AND METHODS FOR TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA | Non-Final OA | The General Hospital Corporation |
| 18000222 | SINGLE CELL COMBINATORIAL INDEXING FROM AMPLIFIED NUCLEIC ACIDS | Final Rejection | THE GENERAL HOSPITAL CORPORATION |
| 18264741 | A CONTINUOUS METRIC TO MEASURE ENDOTYPE AND CORTICOSTEROID INTERACTION IN SEPTIC SHOCK | Final Rejection | VANDERBILT UNIVERSITY |
| 17999960 | NON-EXTENSIBLE OLIGONUCLEOTIDES IN DNA AMPLIFICATION REACTIONS | Non-Final OA | William Marsh Rice University |
| 18372576 | CULTURE-FREE BIPHASIC APPROACH FOR RAPID DETECTION OF PATHOGENS FROM WHOLE BLOOD | Non-Final OA | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS |
| 18578997 | MODIFIED ADAPTERS FOR ENZYMATIC DNA DEAMINATION AND METHODS OF USE THEREOF FOR EPIGENETIC SEQUENCING OF FREE AND IMMOBILIZED DNA | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 18709782 | FRAGMENT CONSENSUS METHODS FOR ULTRASENSITIVE DETECTION OF ABERRANT METHYLATION | Non-Final OA | Foundation Medicine, Inc. |
| 18580427 | COMPOSITIONS AND METHODS FOR DETECTION OF BREAST CANCER | Non-Final OA | Mercy Bioanalytics, Inc. |
| 17631558 | MULTIPLEX LIGATION-DEPENDENT PROBE MICROARRAY DETECTION | Final Rejection | FLASHDX SHENZHEN INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy28.6% of resolved applications examined by Kailey Elizabeth Cash were allowed (21 resolved cases), compared with 45.4% across Art Unit 1637 over the last five years.
This examiner's interview lift is +64.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Kailey Elizabeth Cash took 1,351 days on average from filing to allowance.
Kailey Elizabeth Cash examines applications in Art Unit 1637 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
